Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Artelo Biosciences (ARTL)

Artelo Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ARTL
DateTimeSourceHeadlineSymbolCompany
13/05/202413:00GlobeNewswire Inc.Artelo Biosciences Reports First Quarter 2024 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
10/05/202414:00GlobeNewswire Inc.Artelo Biosciences to Present at the Pharma Partnering Summit 2024 on May 14thNASDAQ:ARTLArtelo Biosciences Inc
23/04/202413:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer TherapyNASDAQ:ARTLArtelo Biosciences Inc
22/04/202413:30GlobeNewswire Inc.Artelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern TimeNASDAQ:ARTLArtelo Biosciences Inc
25/03/202412:00GlobeNewswire Inc.Artelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
12/03/202413:15GlobeNewswire Inc.Artelo Biosciences Selected as a Finalist in Johnson & Johnson’s Innovation ChallengeNASDAQ:ARTLArtelo Biosciences Inc
23/01/202413:30GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Pre-Clinical Research Demonstrating ART26.12’s Effectiveness in Treating and Preventing Oxaliplatin-Induced Peripheral NeuropathyNASDAQ:ARTLArtelo Biosciences Inc
08/01/202413:30GlobeNewswire Inc.Artelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12NASDAQ:ARTLArtelo Biosciences Inc
05/12/202313:30GlobeNewswire Inc.Artelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
30/11/202314:00GlobeNewswire Inc.Artelo Biosciences to Present Important New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in GermanyNASDAQ:ARTLArtelo Biosciences Inc
13/11/202313:02Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
13/11/202313:00GlobeNewswire Inc.Artelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
09/11/202314:00GlobeNewswire Inc.Artelo Biosciences Announces Publication of New Peer-Reviewed Research Demonstrating Protective Properties of ART27.13 Against Muscle Degeneration Caused by Certain CancersNASDAQ:ARTLArtelo Biosciences Inc
02/11/202312:30GlobeNewswire Inc.Artelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023NASDAQ:ARTLArtelo Biosciences Inc
04/10/202313:30GlobeNewswire Inc.Principal Investigator of Artelo’s CAReS Trial to Participate in Medical Expert Webinar Hosted by H.C. Wainwright to Discuss Current Development Strategies for Cancer-Related Anorexia and CachexiaNASDAQ:ARTLArtelo Biosciences Inc
13/09/202313:30GlobeNewswire Inc.Artelo Biosciences to Present at the 13th Congress of the European Pain Federation on September 20thNASDAQ:ARTLArtelo Biosciences Inc
07/09/202313:00GlobeNewswire Inc.Artelo Biosciences Completes Positive Pre-IND Meeting with FDA for ART26.12NASDAQ:ARTLArtelo Biosciences Inc
06/09/202314:00GlobeNewswire Inc.Artelo Biosciences to Present at the 6th Cannabinoid-Derived Drug Development Summit on September 12thNASDAQ:ARTLArtelo Biosciences Inc
05/09/202314:00GlobeNewswire Inc.Artelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thNASDAQ:ARTLArtelo Biosciences Inc
10/08/202313:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ARTLArtelo Biosciences Inc
10/08/202313:00GlobeNewswire Inc.Artelo Biosciences Reports Second Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:ARTLArtelo Biosciences Inc
08/08/202321:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
08/08/202321:34Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
19/07/202314:00GlobeNewswire Inc.Artelo Biosciences to Present New Mechanism of Action Data on ART26.12 at the Gordon Research Conference on July 20, 2023NASDAQ:ARTLArtelo Biosciences Inc
17/07/202305:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ARTLArtelo Biosciences Inc
10/07/202313:30GlobeNewswire Inc.Artelo Biosciences CEO to Participate in the Benzinga All Access Event on July 11NASDAQ:ARTLArtelo Biosciences Inc
07/07/202313:23Edgar (US Regulatory)Form DEL AM - Delaying amendmentNASDAQ:ARTLArtelo Biosciences Inc
06/07/202321:31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:ARTLArtelo Biosciences Inc
03/07/202319:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ARTLArtelo Biosciences Inc
03/07/202319:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ARTLArtelo Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:ARTL

Your Recent History

Delayed Upgrade Clock